Iterum Therapeutics plc - Ordinary Share (ITRM)

Iterum Therapeutics is a biopharmaceutical company focused on developing innovative antibacterial therapies to combat serious infections caused by multidrug-resistant bacteria

The company harnesses its expertise in microbiology and drug development to advance its therapeutic candidates through clinical trials, aiming to provide effective treatment options for patients with limited choices due to rising antibiotic resistance. With a commitment to addressing urgent public health challenges, Iterum Therapeutics is dedicated to delivering next-generation antibiotics that can improve patient outcomes and enhance global health.